Abstract
Meloxicam is a potent non-steroidal anti-inflammatory drug (NSAID) that has been shown to be an effective analagesic and anti-inflammatory in adult horses at a dose rate of 0.6 mg/kg, PO, q 24 h. Pharmacokinetics and safety of this drug have not been reported in foals 6 wk of age.
| Original language | English |
|---|---|
| Pages | 33-33 |
| Number of pages | 1 |
| Publication status | Published - 2009 |
| Event | American Association of Equine Practitioners’ 55th Annual Convention - Mandalay Bay Convention Center, Las Vegas, United States Duration: 05 Dec 2009 → 09 Dec 2009 |
Conference
| Conference | American Association of Equine Practitioners’ 55th Annual Convention |
|---|---|
| Country | United States |
| City | Las Vegas |
| Period | 05/12/09 → 09/12/09 |
Fingerprint Dive into the research topics of 'Pharmacokinetics and Safety of Oral Doses of Meloxicam in Foals Less Than Six Weeks of Age'. Together they form a unique fingerprint.
Cite this
Raidal, S., Pippia, J., & Noble, G. (2009). Pharmacokinetics and Safety of Oral Doses of Meloxicam in Foals Less Than Six Weeks of Age. 33-33. Abstract from American Association of Equine Practitioners’ 55th Annual Convention, Las Vegas, United States.